Last updated: 16 February 2024 at 5:05pm EST

Christine Utter Net Worth




The estimated Net Worth of Christine Marie Utter is at least $5.66 million dollars as of 30 January 2024. Ms. Utter owns over 318 units of PTC Therapeutics Inc stock worth over $1,146,489 and over the last 7 years she sold PTCT stock worth over $2,814,014. In addition, she makes $1,700,120 as Senior Vice President - Finance et Chief Accounting Officer at PTC Therapeutics Inc.

Ms. Utter PTCT stock SEC Form 4 insiders trading

Christine has made over 26 trades of the PTC Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she sold 318 units of PTCT stock worth $8,666 on 30 January 2024.

The largest trade she's ever made was exercising 31,758 units of PTC Therapeutics Inc stock on 4 November 2020 worth over $983,545. On average, Christine trades about 5,133 units every 69 days since 2017. As of 30 January 2024 she still owns at least 35,528 units of PTC Therapeutics Inc stock.

You can see the complete history of Ms. Utter stock trades at the bottom of the page.





Christine Utter biography

Christine Marie Utter serves as Senior Vice President - Finance, Chief Accounting Officer of the Company. Ms. Utter joined the Company in 2010 as the Assistant Controller and became Senior Vice President, Finance, in January 2017. From 2005 until 2009, Ms. Utter was the Assistant Corporate Controller of Barrier Therapeutics, a pharmaceutical company. Prior to 2005, Ms. Utter held positions as a financial analyst at Engelhard Corporation and as an auditor at both Ernst & Young LLP and Arthur Andersen. Ms. Utter holds a B.S. in accounting from The College of New Jersey, and is a certified public accountant.

What is the salary of Christine Utter?

As the Senior Vice President - Finance et Chief Accounting Officer of PTC Therapeutics Inc, the total compensation of Christine Utter at PTC Therapeutics Inc is $1,700,120. There are 5 executives at PTC Therapeutics Inc getting paid more, with Stuart Peltz having the highest compensation of $7,759,440.



How old is Christine Utter?

Christine Utter is 42, she's been the Senior Vice President - Finance et Chief Accounting Officer of PTC Therapeutics Inc since 2019. There are 18 older and 1 younger executives at PTC Therapeutics Inc. The oldest executive at PTC Therapeutics Inc is Dr. Allan Steven Jacobson, 75, who is the Independent Co-Founder, Chairman of Scientific Advisory Board & Director.

What's Christine Utter's mailing address?

Christine's mailing address filed with the SEC is C/O PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD, NJ, 07080.

Insiders trading at PTC Therapeutics Inc

Over the last 12 years, insiders at PTC Therapeutics Inc have traded over $50,602,930 worth of PTC Therapeutics Inc stock and bought 3,730,934 units worth $57,374,337 . The most active insiders traders include Suisse/ Credit, Adam Koppel et Bioventures Cayman Ltd Hbm. On average, PTC Therapeutics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $888,748. The most recent stock trade was executed by Pierre Gravier on 16 July 2024, trading 2,269 units of PTCT stock currently worth $77,191.



What does PTC Therapeutics Inc do?

ptc is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. while ptc’s discovery programs are directed at targets in multiple therapeutic areas, ptc is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. ptc’s internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. for more information on the company, please visit our website www.ptcbio.com.



What does PTC Therapeutics Inc's logo look like?

PTC Therapeutics Inc logo

Complete history of Ms. Utter stock trades at PTC Therapeutics Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
30 Jan 2024 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 318 $27.25 $8,666
30 Jan 2024
35,528
8 Jan 2024 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 2,841 $28.86 $81,991
8 Jan 2024
35,846
21 Apr 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 4,692 $33.02 $154,930
21 Apr 2023
38,430
29 Mar 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 4,688 $40.45 $189,630
29 Mar 2023
42,747
27 Mar 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 26,658 $33.02 $880,247
27 Mar 2023
47,788
31 Jan 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 325 $45.63 $14,830
31 Jan 2023
38,059
10 Jan 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 906 $43.59 $39,493
10 Jan 2023
38,384
9 Jan 2023 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 706 $41.66 $29,412
9 Jan 2023
39,290
1 Feb 2022 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 1,020 $40.26 $41,065
1 Feb 2022
25,405
18 Jan 2022 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 11,428 $43.94 $502,146
18 Jan 2022
26,425
7 Jan 2022 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 747 $38.53 $28,782
7 Jan 2022
16,253
8 Feb 2021 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 2,657 $33.02 $87,734
8 Feb 2021
19,166
1 Feb 2021 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 1,020 $57.39 $58,538
1 Feb 2021
16,509
13 Jan 2021 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 3,947 $66.57 $262,752
13 Jan 2021
17,529
5 Jan 2021 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 316 $62.37 $19,709
5 Jan 2021
9,488
4 Nov 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 31,758 $30.97 $983,545
4 Nov 2020
12,218
5 Oct 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 3,287 $16.39 $53,874
5 Oct 2020
12,062
6 Jul 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 3,288 $16.39 $53,890
6 Jul 2020
12,062
17 Apr 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 2,145 $18.01 $38,631
17 Apr 2020
11,449
3 Apr 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 787 $11.23 $8,838
3 Apr 2020
10,091
6 Jan 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 14,110 $49.97 $705,077
6 Jan 2020
5,224
2 Jan 2020 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 3,150 $11.23 $35,375
2 Jan 2020
6,372
28 Jun 2019 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Exercice d'option 14,059 $20.81 $292,568
28 Jun 2019
14,234
5 Mar 2019 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 28,709 $34.97 $1,003,954
5 Mar 2019
4,937
7 Jan 2019 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 297 $34.75 $10,321
7 Jan 2019
7,446
3 Jan 2018 Christine Marie Utter
Vice-président senior et Chef de comptabilité
Vente 412 $17.67 $7,280
3 Jan 2018
6,660


PTC Therapeutics Inc executives and stock owners

PTC Therapeutics Inc executives and other stock owners filed with the SEC include: